Thursday, April 22, 2021

Average-risk individuals may prefer stool-based test over colonoscopy for cancer screening

When given a choice, most individuals with an average risk of colorectal cancer said they would prefer a stool-based screening test for colorectal cancer over colonoscopy, the method most often recommended by health care providers.

from Top Health News -- ScienceDaily https://ift.tt/3nb98Ch

No comments:

Post a Comment

FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001...